Adunarea Generala Ordinara a ActionarilorPlan de Investitii 2019 Nota: Activele mentionate in Planul...

23 Aprilie 2019

Adunarea Generala Ordinara a Actionarilor

Agenda

Situatia Rezultatului Global

Bugetul de Venituri si Cheltuieli 2019

Plan de Investitii

Evolutie numerar si echivalente numerar

Pozitia companiei pe piata

Intrebari si Raspunsuri

Evolutia indicatorilor financiari 2017 vs. 2018

38,4

Cifra Afaceri Active Totale EBITDA Profit Net

170,2184,2

262,4

285,5

49,558,5

36,0

+8%

+9%

+18%

+7%

2017 2018

Agenda



Plan de Investitii




Buget venituri si cheltuieli 2019

Realizat 2017 Realizat 2018 Buget 2019Realizat

2018/2017

Bugetat 2019

/Realizat 2018

Venituri din vanzari 170,232,296 184,236,168 202,839,302 8% 10%

Alte venituri din exploatare 487,491 1,218,322 650,000 150% -47%

Variatia stocurilor (50,747) 216,379 1,200,000 -526% 455%

Materii prime si consumabile (39,527,901) (40,475,299) (45,368,147) 2% 12%

Cheltuieli de personal (26,173,666) (31,087,336) (34,706,081) 19% 12%

Amortizare (7,058,665) (12,094,830) (10,698,756) 71% -12%

Alte cheltuieli din exploatare (55,421,929) (55,594,115) (65,472,021) 0% 18%

Profit/ (Pierdere) din exploatare42,486,879 46,419,289 48,444,298 9% 4%

Venituri / (costuri) financiare nete191,143 754,446 840,000 295% 11%

Profit/ (Pierdere) inainte de impozitare42,678,022 47,173,735 49,284,298 11% 4%

Cheltuieli cu impozite(6,650,299) (8,748,795) (7,885,488) 32% -10%

Profit / (Pierdere)36,027,723 38,424,940 41,398,810 7% 8%

Nota:

1. Pentru anul 2019 in categoria cheltuieli de personal a fost prevazuta suma de 1.200.000 lei pentru tichete de masa si suma de 300.000 lei tichete

cadou oferite angajatilor ca ajutoare sociale, conform legislatiei in vigoare

2. Pentru sustinerea activitatii de promovare in piata a produselor Biofarm, in cadrul bugetului 2019 a fost prevazuta in categoria “Alte cheltuieli

din exploatare” o suma de pana la 1.000.000 lei pentru tichete cadou.

3. In conditiile in care evolutia pietei permite depasirea cifrei de afaceri si/sau atingerea tintei de profit net, se pot angaja cheltuieli suplimentare.

Agenda



Plan de Investitii




Plan de Investitii 2019

Nota:Activele mentionate in Planul de Investitii pentru fabrica noua din Gura Badicului vor fi achizitionate progresiv, in functie de finalizarea

cladirilor si a spatiilor de productie.

DescriereCAPEX 2018 Ron

aprobatContractat 2018

CAPEX 2018 Ron

aprobat - neangajat

CAPEX aditional

2019CAPEX 2019

Lucrari 2,380,800 272,182 2,108,618 2,662,757 4,771,375

Instalatii 4,445,400 910,095 3,535,305 3,391,952 6,927,258

Echipamente 26,346,900 9,090,451 17,256,449 4,826,301 22,082,750

Echipamente de productie

Fabrica Logofatul Tautu651,930 530,800 121,130 (121,130)

Echipamente de laborator 560,325 117,319 443,006 (443,006)

Amenajare cladiri si spatii

comune593,750 593,750

Investitii auto 2,790,000 846,215 1,943,785 (708,785) 1,235,000

IT echipamente si software 2,148,347 333,887 1,814,460 (433,350) 1,381,110

TOTAL 39,323,702 12,100,948 27,222,754 9,768,489 36,991,243

Agenda



Plan de Investitii




15

40

50

0

20

5

10

25

30

60

35

55

45

JulJan Oct

17,6

17-Dec Jun Aug Sep Nov

37,0

15,4

45,7

DecFeb Mar Apr May

12,8

+26%

+15%

Valoare depoziteCifra afaceriIncasari Disponibil finalPlati

Evolutie numerar si echivalentenumerar

Agenda



Plan de Investitii




Sursa – Date Cegedim

Rank CORPORATIONUnits

2017

Units

2018

UC Evolutie

2018 vs

2017

MS 2018

TOTAL PIATA

FARMACEUTICA578,623,808 612,663,191 5.88%

1 SUN PHARMA 50,100,435 54,902,912 9.59% 8.96%

2 ZENTIVA 37,043,503 38,973,842 5.21% 6.36%

3 SERVIER 33,539,063 36,618,507 9.18% 5.98%

4 KRKA D.D. 32,201,598 33,981,628 5.53% 5.55%

5 ANTIBIOTICE 31,340,136 32,086,728 2.38% 5.24%

6 SANOFI 26,817,888 29,942,313 11.65% 4.89%

7 GLAXOSMITHKLINE 25,344,777 28,977,909 14.33% 4.73%

8 ALVOGEN 26,962,129 24,960,519 -7.42% 4.07%

9 NOVARTIS 23,245,782 22,933,970 -1.34% 3.74%

10 GEDEON RICHTER 20,860,159 21,819,521 4.60% 3.56%

11 BIOFARM 19,798,841 21,348,282 7.83% 3.48%

Rank CORPORATIONValues PPP 2017

RON

Values PPP 2018

RON

VAL PPP

Evolutie

2018 vs

2017

MS 2018

TOTAL PIATA

FARMACEUTICA14,121,579,465 16,068,719,842 13.79%

1 ABBVIE 1,100,061,882 1,086,078,394 -1.27% 6.76%

2 SANOFI 666,755,500 809,285,935 21.38% 5.04%

3 MERCK & CO 348,662,398 722,302,608 107.16% 4.50%

4 NOVARTIS 626,239,740 708,324,866 13.11% 4.41%

5 SERVIER 626,654,888 689,075,005 9.96% 4.29%


7 SUN PHARMA 553,444,921 632,262,641 14.24% 3.93%

8 PFIZER 578,907,976 625,795,555 8.10% 3.89%

9 ASTRAZENECA 466,788,381 547,023,141 17.19% 3.40%

10 BRISTOL MYERS SQUIBB 415,383,996 496,181,188 19.45% 3.09%

23 BIOFARM 199,993,214 227,697,283 13.85% 1.42%


2017

Units

2018

UC Evolutie

2018 vs

2017

MS 2018

TOTAL PIATA OTC + SN 194,090,484 207,924,911 7.13%

1 SUN PHARMA 20,395,494 21,650,317 6.15% 10.41%

2 BIOFARM 16,696,491 18,368,099 10.01% 8.83%

3 SANOFI 13,315,408 15,770,198 18.44% 7.58%


5 RECKITT BENCKISER 12,404,456 14,506,847 16.95% 6.98%

6 ALVOGEN 7,317,869 6,663,741 -8.94% 3.20%

7 BAYER HEALTHCARE AG 6,549,864 6,551,967 0.03% 3.15%

8 NATUR PRODUKT ZDROVIT 4,838,110 6,219,246 28.55% 2.99%

9 NOVARTIS 5,154,248 5,624,159 9.12% 2.70%

10 FITERMAN PHARMA 5,943,795 5,373,508 -9.59% 2.58%


RON

Values PPP 2018

RON

VAL PPP

Evolutie

2018 vs

2017

MS 2018

TOTAL PIATA OTC + SN 3,104,491,542 3,552,229,832 14.42%


2 SUN PHARMA 217,837,027 239,551,974 9.97% 6.74%

3 SANOFI 181,149,516 230,885,015 27.46% 6.50%

4 BIOFARM 187,237,331 215,272,647 14.97% 6.06%


6 ASCENDIS HEALTH 154,621,328 183,783,574 18.86% 5.17%

7 NOVARTIS 106,979,179 123,792,278 15.72% 3.48%



10 FITERMAN PHARMA 112,044,641 105,765,417 -5.60% 2.98%




2017

Units

2018

UC Evolutie

2018 vs

2017

MS 2018

TOTAL PIATA SN 54,755,871 58,380,854 6.62%

1 BIOFARM 5,525,986 6,045,122 9.39% 10.35%


3 ASCENDIS HEALTH 4,567,451 5,147,977 12.71% 8.82%

4 FITERMAN PHARMA 3,436,488 3,143,539 -8.52% 5.38%

5 ALVOGEN 2,496,938 2,476,319 -0.83% 4.24%

6 WALMARK 2,567,796 2,443,826 -4.83% 4.19%

7 SUN PHARMA 2,428,385 2,398,931 -1.21% 4.11%

8 PERRIGO 2,249,646 2,142,827 -4.75% 3.67%

9 HIMALAYA 1,711,319 1,806,009 5.53% 3.09%



RON

Values PPP 2018

RON

VAL PPP

Evolutie

2018 vs

2017

MS 2018

TOTAL PIATA SN 1,176,948,813 1,347,383,179 14.48%

1 ASCENDIS HEALTH 144,873,083 174,919,141 20.74% 12.98%


3 BIOFARM 70,318,633 82,969,696 17.99% 6.16%

4 WALMARK 77,955,530 80,788,241 3.63% 6.00%

5 FITERMAN PHARMA 60,374,715 58,577,005 -2.98% 4.35%

6 ALVOGEN 45,236,520 45,206,130 -0.07% 3.36%


8 HIMALAYA 35,546,340 43,276,282 21.75% 3.21%

9 SUN PHARMA 37,816,357 40,185,817 6.27% 2.98%

10 PERRIGO 36,691,714 36,231,613 -1.25% 2.69%


2017

Units

2018

UC Evolutie

2018 vs

2017

MS 2018

TOTAL PIATA OTC 139,334,613 149,544,057 7.33%

1 SUN PHARMA 17,967,109 19,251,386 7.15% 12.87%

2 SANOFI 13,213,070 15,625,181 18.26% 10.45%



5 BIOFARM 11,170,505 12,322,977 10.32% 8.24%

6 BAYER HEALTHCARE AG 4,983,148 4,771,239 -4.25% 3.19%

7 ANTIBIOTICE 4,761,677 4,590,557 -3.59% 3.07%

8 GEDEON RICHTER 4,176,270 4,319,494 3.43% 2.89%

9 JOHNSON & JOHNSON 3,801,261 4,224,122 11.12% 2.82%

10 ALVOGEN 4,820,931 4,187,422 -13.14% 2.80%


RON

Values PPP 2018

RON

VAL PPP

Evolutie

2018 vs

2017

MS 2018

TOTAL PIATA OTC 1,927,542,729 2,204,846,653 14.39%


2 SANOFI 178,949,036 227,118,891 26.92% 10.30%


4 SUN PHARMA 180,020,670 199,366,157 10.75% 9.04%

5 BIOFARM 116,918,698 132,302,951 13.16% 6.00%

6 NOVARTIS 78,986,763 87,876,603 11.25% 3.99%

7 BAYER HEALTHCARE AG 80,535,264 78,041,335 -3.10% 3.54%

8 MENARINI 63,517,714 66,979,704 5.45% 3.04%

9 JOHNSON & JOHNSON 58,112,550 65,355,198 12.46% 2.96%

10 ANGELINI 45,805,979 57,745,458 26.07% 2.62%


Impartirea venitului pe categorii

Cu cele 62 de branduri suntem prezenti in 10 piete din

CEGEDIM :

8 Branduri Biofarm sunt nr 1

in categoriile lor ATC4

31 de branduri sunt in primele 5 pozitii in categoriile lor

7 Branduri Biofarm ocupa locul nr 2 16 Branduri Biofarm sunt in pozitiile

3-5

• tract digestiv• sistem respirator• sistem nervos• sistem cardiovascular• dermatologie

• tract urinar• sistem musculo-scheletal• parazitologie• sensory organs• Sistem sangvin

Brand BiofarmMS

Units 2018

BIXTONIM SOLUTIE 34.35%

CARMOL SOLUTIE 94.24%

COLEBIL 55.49%

HERBAFLU INHALANT 94.96%

NERVOCALMIN 16.61%

TRIFERMENT 58.10%

Vitamina A 99.34%

Vitamina E 92.05%

Brand BiofarmMS

Units 2018

BIXTONIM XYLO 27.75%

BROCRIPTIN 16.24%

CARBOCIT 29.58%

COLCHICINA 12.64%

EXTRAVALERIANIC BIOFARM CARDIO 17.61%

SENNALAX COMPRIMATE, SIROPURI 36.01%

VITAMINA A + D2 30.97%

Brand BiofarmMS

Units 2018

ANGHIROL 10.41%

BORAMID 12.90%

DEVARICID COMPRIMATE 9.20%

HEPATOPROTECT 9.99%

SOL CLORAMFENICOL FLUOCINOLONL 28.86%

CAVIT 7.58%

MAGNEFORT 9.13%

METOCLOPRAMID 3.58%

OSSIDENTA 10.38%

PROTECARDIN 2.14%

VERMIGAL 10.46%

BIOLAND ULEI DE PESTE D2 3.28%

DIABETICARE 2.71%

DIFEBIOM 7.25%

ROFEDEX SIROP 5.14%

VITAMINA D3 3.25%

Pozitia brandurilor in piata


Sursa: Date CEGEDIM

BIOFARM

Values PPP

2017RON

Values PPP

2018RON

Values PPP

% Growth on Any2018

RONRef 2017

Values PPP

ABS Growth on Any2018

RONRef 2017

MS BIOFARM

Values PPP2018

RON

RANK (Values

PPP2018

RON)

199,993,222 227,697,284 13.85% 27,704,062

TRIFERMENT 28,047,660 31,579,856 12.59% 3,532,196 52.22% 1

COLEBIL 27,159,443 28,309,517 4.23% 1,150,074 51.61% 1

BIXTONIM XYLO 14,829,304 15,660,136 5.60% 830,832 25.79% 2

HEPATOPROTECT 11,716,921 15,474,779 32.07% 3,757,858 7.59% 5

CARMOL SOLUTIE 9,714,146 14,562,226 49.91% 4,848,080 96.96% 1BIXTONIM SOLUTIE 11,773,978 13,408,952 13.89% 1,634,974 20.92% 2

SENNALAX COMPRIMATE, SIROPURI 10,255,239 12,403,723 20.95% 2,148,484 32.25% 2

DEVARICID COMPRIMATE 9,558,309 10,081,772 5.48% 523,463 7.56% 3

NERVOCALMIN 5,380,285 6,855,120 27.41% 1,474,835 14.03% 3

CARBOCIT 6,090,316 6,608,270 8.50% 517,954 20.34% 3

ANGHIROL 5,618,379 6,593,326 17.35% 974,947 12.02% 3

EXTRAVALERIANIC BIOFARM CARDIO 3,901,223 5,487,079 40.65% 1,585,856 31.90% 2

PROTECARDIN 2,522,452 2,190,637 -13.15% -331,815 1.83% 4

OTHERS 53,425,567 58,481,891 9.46% 5,056,324

Evolutie principalele branduri

ATC4 CORPORATION BRAND

MS Values

PPP

2018

RON

RANK

BIOFARM TRIFERMENT 52.22% 1

MYLAN KREON 16.78% 2

ALVOGEN DIGENZYM PLUS 10.24% 3

BIOFARM COLEBIL 51.61% 1

SUN PHARMA FIOBILIN 17.38% 2

BIOFARM ANGHIROL 12.02% 3

PHARCO PHARM. BILICHOL 5.78% 4

ROWA WAGNER ROWACHOL 4.70% 5

SANOFI ESSENTIALE FORTE 22.78% 1

HIMALAYA LIV 52 9.86% 2

SUN PHARMA FORTIFIKAT 8.30% 3

WORWAG PHARMA LAGOSA 7.60% 4

BIOFARM HEPATOPROTECT 7.59% 5

JOHNSON & JOHNSON OLYNTH 44.63% 1

BIOFARM BIXTONIM XYLO 25.79% 2

GLAXOSMITHKLINE VIBROCIL 7.58% 3

LAB. THEA BIORINIL 29.69% 1

BIOFARM BIXTONIM solutie 20.92% 2

MERCK & CO NASONEX 11.82% 3

BIOFARM CARMOL (fara gel) 96.96% 1

TIS FARMACEUTIC SALMET T sol.ext. 1.34% 2

LAROPHARM LAROGRIP 1.62% 3

A9A0 (DIGESTIVES, INCLUDING

ENZYMES)

A5A1 (CHOLERETICS AND

CHOLEKINETICS)

R1A7 (NASAL DECONGESTANTS)

NASAL CORTICOSTEROIDS

WITHOUT ANTI-INFECTIVES)

M2A0 (TOPICAL ANTI-RHEUMATICS

AND ANALGESICS)

A5B0 (HEPATIC PROTECTORS,

LIPOTROPICS)

ATC4 CORPORATION BRAND

MS Values

PPP

2018

RON

RANK

SANOFI DULCOLAX 35.96% 1

BIOFARM SENNALAX 32.25% 2

SOLACIUM PHARMA SOLACIUM PHARMA 7.31% 3

SERVIER DETRALEX 70.15% 1

ANTIBIOTICE FLUXIV 8.21% 2

BIOFARM DEVARICID 7.56% 3

ASCENDIS HEALTH STRESCLIN 20.73% 1

LAB. BOIRON SEDATIF PC 15.20% 2

BIOFARM NERVOCALMIN 14.03% 3

MENARINI ESPUMISAN 46.58% 1

SUN PHARMA KEBENE 23.88% 2

BIOFARM CARBOCIT 20.34% 3

ZENTIVA EXTRAVERAL 53.65% 1

BIOFARM EXTRAVALERIANIC BIOFARM CARDIO31.90% 2

DR. REDDY'S LAB. VAGOSTABYL 13.29% 3

SUN PHARMA ASPENTER 73.95% 1

BAYER HEALTHCARE AG ASPIRIN CARDIO 13.62% 2

GALENICA AFLEN 3.79% 3

BIOFARM PROTECARDIN 1.83% 4

B1C1 (CYCLO-OXIGENASE INHIBITOR

PLATELET AGGREGATION

INHIBITORS)

A6A2 (STIMULANT LAXATIVES)

C5C0 (VARICOSE THERAPY,

SYSTEMIC)

N5B5 (HERBAL

HYPNOTICS/SEDATIVES)

A2A2 (PLAIN ANTIFLATULENTS

AND CARMINATIVES)

fara suspensiile pentru copii

CARDIOVASCULAR PRODUCTS

Principalele branduri Biofarm vs. competitorii relevanti


Agenda



Plan de Investitii




Adunarea Generala Ordinara a ActionarilorPlan de Investitii 2019 Nota: Activele mentionate in Planul...

Documents

Transcript of Adunarea Generala Ordinara a ActionarilorPlan de Investitii 2019 Nota: Activele mentionate in Planul...